Thursday, 12. June 2008   17:30-18:00 REGISTRATION AT THE LOBBY OF UNIVERSITY OF TARTU, ÜLIKOOLI 18 18:00-19:00 OPENING OF THE CONFERENCE Chaired by Prof. Richard Villems, President of the Estonian Academy of Sciences, Director of the Estonian Biocentre, Estonia (Ülikooli str 18). Keynote Dr. David Gurvitz, Tel Aviv University, Israel "Personalized Medicine: Setting the Priorities." 19:00-21:00 Welcome Reception In the Museum of Tartu University History (Lossi 25) Friday, 13. June 2008   08:30-09:00 REGISTRATION AT THE DORPAT CONFERENCE CENTRE (SOOLA 6) 09:00-10:20 SESSION I Chaired by Prof. Alar Karis, Rector of the University of Tartu, Estonia. Prof. Frank Grosveld, The Department of Cell Biology, Erasmus University, The Netherlands "Transcription factors and genomic interactions" Prof. Eero Castren, Neuroscience Center, University of Helsinki, Finland "Epigenetic regulation of neurotrophic factor gene expression by drugs and environmental factors" 10:20-10:40 Coffee/tea break 10:40-12:00 SESSION II Chaired by Dr. Andres Soosaar, Chairman of the Ethics Review Committee on Human Research of the University of Tartu, Estonia. Prof. Bernice Elger, University Center of Legal Medicine of West Switzerland, University of Geneva, Switzerland "Ethical and regulatory aspects of biobanks: global consensus and controversies (Results from a worldwide expert consultation)" Mr. Andres Liivak, ReedSmith, USA Current and future life sciences deal structures: What has historically shaped and what currently is shaping big pharma/biotech partnering deals, including today's precedent setting deal structures in U.S. - India branded R&D - what this may mean for future Baltic and Scandinavian life sciences deals and consideration of selected best practices in life sciences deal making. 12:00-13:30 Lunch 13:30-15:30 SESSION III Chaired by Prof. Tõnis Timmusk, Head of the Department of Molecular Biology, Tallinn University of Technology, Estonia. Prof. Maido Remm, Department of Bioinformatics, University of Tartu, Estonia "Consensus human genome" Prof. Xavier Estivill, Genes and Disease Programme, Centre for Genomic Regulation, Pompeu Fabra University, Spain "Copy number variants: an emerging mechanism of susceptibility to disease" Dr. Manolis Dermitzakis, Team of Population and Comparative Genomics, The Wellcome Trust Sanger Institute, United Kingdom "Population Genomics of human gene expression" 15:30-15:50 Coffee/tea break 15:50-17:50 SESSION IV Chaired by Prof. Andres Metspalu, Head of the Department of Biotechnology, Director of the Estonian Genome Project, University of Tartu, Estonia. Prof. Gerd Schmitz, University Hospital Regensburg, Germany "From biobanking to biomarkers" Dr. Andreas Dahlgren, Illumina UK Ltd, UK "From Whole-Genome to Whole Solution - Latest Next Generation Disease Analysis Tools from Illumina." Dr. Britta Finkelnburg, Applied Biosystems, Germany "Expanding the boundaries of genomic analysis with SOLiDTM System — A revolution in next generation technology (The Future is Today!)" 20:00 Buffet Dinner In the restaurant Atlantis (Narva road 2) Saturday, 14. June 2008   09:00-11:00 SESSION V Chaired by Prof. Toomas Veidebaum, Research Director of the National Institute for Health Development, Estonia. Prof. Pier Franco Pignatti, Faculty of Medicine and Surgery, University of Verona, Italy "Gene environment interactions in coronary atherosclerosis" Prof. Kari Hemminki, Division of Molecular Genetic Epidemiology, German Cancer Research Center, Germany "Familial cancer and cancer genes" Prof. Adi Gazdar, Southwestern Medical Center, University of Texas, Dallas, USA "EGFR pathway deregulation in lung cancer – implications for targeted therapies." 11:00-11:20 Coffee/tea break 11:20-12:40 SESSION VI Chaired by Prof. Vaidutis Kucinskas, President of the Lithuanian Society of Human Genetics, Director of the Centre for Medical Genetics, Lithuania. Dr. Janis Klovins, Latvian Biomedical Research and Study Center, Latvia "Latvian Genome Database: establishing resources for genome research" Prof. Per Magnus, Norwegian Institute of Public Health, Norway "Understanding the genetic basis of disease by using a large, population-based pregnancy cohort" 12:40-14:10 Lunch 14:10-15:30 SESSION VII Chaired by Prof. Tiina Talvik, Tartu University Children’s Clinic, Estonia. Dr. Segolene Ayme, INSERM - National Institute of Health and Medical Research, France "Classification of genetic diseases for communication purpose between clinicians and biologists: New tools provided by Orphanet." Prof. Jean Jacques Cassiman, Centre for Human Genetics, Catholic University of Leuven, Belgium "Contribution of EuroGentest to quality genetic testing" 15:30-15:50 Coffee/tea break 15:50-17:10 SESSION VIII Chaired by Dr. Jaanus Pikani, Chairman of the Estonian Biotechnology Association, Estonia. Prof. Ülo Langel, Department of Neurochemistry, Stockholm University, Sweden "Regulation of gene expression by application of cell penetrating peptides" Dr. Krista Kaasik, Laboratories of Neurogenetics, University of California in San Francisco, USA "Elucidating the regulation of the mammalian circadian clock" 17:10 CLOSE OF THE CONFERENCE Close of the Conference by Prof. Andres Metspalu, University of Tartu, Estonia.